Mozafancogene autotemcel clinical trials
Also written RP-L102.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses mozafancogene autotemcel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- RP-L102
- 3
Studies by the year they started
3 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Rocket Pharmaceuticals Inc. (3)
Studies
Open first, then newest update. How each study uses mozafancogene autotemcel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Gene Therapy for Fanconi Anemia, Complementation Group AActive, not recruitingPhase 2Rocket Pharmaceuticals Inc.NCT04248439Written as RP-L102
- Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype AActive, not recruitingPhase 2Rocket Pharmaceuticals Inc.NCT04069533Written as RP-L102
- A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype AStatus unknownPhase 1Rocket Pharmaceuticals Inc.NCT03814408Written as RP-L102
Codes
What other systems call mozafancogene autotemcel · ClinicalTrials.gg INT016302
- UNII (FDA) D82H29W72KMOZAFANCOGENE AUTOTEMCELOne source FDA
- NCI Thesaurus C173602Mozafancogene AutotemcelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | D82H29W72K | MOZAFANCOGENE AUTOTEMCEL | One source FDA |
| NCI Thesaurus | C173602 | Mozafancogene Autotemcel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.